Artera Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
300
- Latest Deal Type
-
Series D
- Latest Deal Amount
-
$65M
- Investors
-
23
Artera General Information
Description
Developer of a patient communication platform designed to manage routine communication between healthcare providers and patients. The company's platform offers voice, text, and email agents integrated with electronic health record systems for scheduling, patient intake, referrals, payments, and care outreach, enabling healthcare providers to manage patient communication and administrative tasks.
Contact Information
Website
www.artera.ioCorporate Office
- 1025 Chapala Street
- Santa Barbara, CA 93101
- United States
Corporate Office
- 1025 Chapala Street
- Santa Barbara, CA 93101
- United States
Artera Timeline
Artera Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 15. Later Stage VC (Series D) | 03-Dec-2025 | $65M | Completed | Generating Revenue | ||
| 14. Later Stage VC | 20-Nov-2023 | Completed | Generating Revenue | |||
| 13. Later Stage VC | 31-Jul-2022 | Completed | Generating Revenue | |||
| 12. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 11. Later Stage VC (Series C1) | 08-Sep-2021 | Completed | Generating Revenue | |||
| 10. Accelerator/Incubator | 01-Jan-2021 | Completed | Generating Revenue | |||
| 9. Later Stage VC (Series C) | 24-Nov-2020 | Completed | Generating Revenue | |||
| 8. Secondary Transaction - Private | 01-Jul-2020 | Completed | Generating Revenue | |||
| 7. Early Stage VC (Series B) | 11-Oct-2019 | $12M | $25.3M | Completed | Generating Revenue | |
| 6. Early Stage VC (Series A) | 02-Nov-2018 | $10.3M | $13.3M | Completed | Generating Revenue |
Artera Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C-1 | ||||||||
| Series C | ||||||||
| Series B | ||||||||
| Series A | 10,677,605 | $0.000100 | $0.06 | $1.08 | $1.08 | 1x | $1.08 | 19.03% |
| Seed | 5,313,308 | $0.000100 | $0.03 | $0.52 | $0.52 | 1x | $0.52 | 9.47% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Artera Comparisons
Industry
Financing
Details
Artera Competitors (55)
One of Artera’s 55 competitors is Conversa, a Formerly VC-backed company based in Portland, OR.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Conversa | Formerly VC-backed | Portland, OR | ||||
| GetWellNetwork | Private Equity-Backed | Bethesda, MD | ||||
| Luma Health | Venture Capital-Backed | San Mateo, CA | ||||
| HealthHub (Enterprise Systems) | Formerly VC-backed | Mississauga, Canada | ||||
| Buddy Healthcare | Formerly VC-backed | Helsinki, Finland |
Artera Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Artera Patents
Artera Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025250679-A1 | Methods and systems for digital pathology assessment of cancer via deep learning | Pending | 30-May-2024 | ||
| US-20250054624-A1 | Methods and systems for digital pathology assessment of cancer via deep learning | Pending | 02-Jun-2023 | ||
| US-20250005745-A1 | Systems and methods for determining cancer therapy via deep learning | Pending | 02-Jun-2023 | ||
| EP-4483381-A1 | Systems and methods for determining cancer therapy via deep learning | Pending | 24-Feb-2022 | ||
| EP-4483381-A4 | Systems and methods for determining cancer therapy via deep learning | Pending | 24-Feb-2022 | G16H20/10 |
Artera Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Artera Investors (23)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Bow River Capital | PE/Buyout | Minority | ||
| Heritage Medical Systems | Corporation | Minority | ||
| Aramco Ventures | Corporate Venture Capital | Minority | ||
| EDBI | Venture Capital | Minority | ||
| Spur Capital Partners | Fund of Funds | Minority |
Artera FAQs
-
When was Artera founded?
Artera was founded in 2015.
-
Where is Artera headquartered?
Artera is headquartered in Santa Barbara, CA.
-
What is the size of Artera?
Artera has 300 total employees.
-
What industry is Artera in?
Artera’s primary industry is Other Healthcare Technology Systems.
-
Is Artera a private or public company?
Artera is a Private company.
-
What is Artera’s current revenue?
The current revenue for Artera is .
-
How much funding has Artera raised over time?
Artera has raised $159M.
-
Who are Artera’s investors?
Bow River Capital, Heritage Medical Systems, Aramco Ventures, EDBI, and Spur Capital Partners are 5 of 23 investors who have invested in Artera.
-
Who are Artera’s competitors?
Conversa, GetWellNetwork, Luma Health, HealthHub (Enterprise Systems), and Buddy Healthcare are some of the 55 competitors of Artera.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
